3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1
2
Phase 3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Prostatic Neoplasms
8
Lung Neoplasms
8
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Melanoma
5
Carcinoma, Non-Small-Cell Lung
5
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Glioblastoma
4
Colorectal Neoplasms
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Glioma
3
Fallopian Tube Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma, Hepatocellular
3
Burkitt Lymphoma
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroblastoma
2
Meningioma
2
Lymphoma, B-Cell
2
Endometrial Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Merkel Cell
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
sargramostim
1
rebastinib
1
pembrolizumab
1
X-Rays
1
Specimen Handling
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
DCC-2036
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Biopsy
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Carcinosarcoma
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled